Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 38 of 98, showing 5 Applications out of 486 total, starting on record 186, ending on 190

# Protocol No Study Title Investigator(s) & Site(s)

186.

ECCT/21/07/03   GBT_131 Inclacumab-Ps 3 Trial.
    A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vaso-occlusive Crises   
Principal Investigator(s)
1. Prof Jessie N Githanga
2. Fredrick Sirwa Chite
3. Bernhards Ragama Ogutu
4. Videlis N Nduba
Site(s) in Kenya
1. International Cancer Institute (ICI)-Eldorate (Uasin Gishu county)
2. KEMRI/CRDR (Nairobi City county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. Gertrude’s Children’s Hospital. (Nairobi City county)
5. Strathmore University Medical Centre (Nairobi City county)
 
View

187.

ECCT/21/06/15   Therapeutic Efficacy Study
    Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the treatment of uncomplicated Plasmodium falciparum malaria in Siaya and Bungoma counties, Kenya.   
Principal Investigator(s)
1. Dr. Sarah-Blythe Ballard
2. Dr. Willis Akhwale
3. Dr. Grace Ikahu
4. Dr. George Githuka
5. Dr. Dickson Mtungu Mwakangalu
6. Dr. Elvis Omondi Oyugi
7. Hellen Gatakaa
8. Regina Jepkosgei Kandie
9. Dr. Fredrick Ouma Odhiambo
Site(s) in Kenya
1. Mahonge Health Center (Bung\'oma county)
2. Kaluo Health Center (Siaya county)
 
View

188.

ECCT/21/06/08   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted   Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Saleh Mansoor
Site(s) in Kenya
1. Aga Kahn University Nairobi (Nairobi City county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county)
6. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county)
7. Kenya Medical Research Institute (Nairobi City county)
8. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
9. Moi University Clinical Research Centre (Uasin Gishu county)
10. KEMRI CCR-Butere County Hospital Site (Kakamega county)
 
View

189.

ECCT/21/06/06   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted  Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. KEMRI CCR-Butere County Hospital Site (Kakamega county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Nairobi City county)
7. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
8. Moi University Clinical Research Centre (Uasin Gishu county)
9. Aga Khan University Hospital (Nairobi City county)
10. Kenya Medical Research Institute (Kisumu county)
11. KEMRI/Walter Reed Project Research Center (Kericho county)
12. Ganjoni Clinic (Mombasa county)
13. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
14. Kenya Medical Research Institute (Nairobi City county)
15. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
16. Moi University Clinical Research Centre (Uasin Gishu county)
17. Aga Khan University Hospital (Nairobi City county)
18. Kenya Medical Research Institute (Kisumu county)
19. KEMRI/Walter Reed Project Research Center (Kericho county)
20. Ganjoni Clinic (Mombasa county)
21. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
22. Kenya Medical Research Institute (Nairobi City county)
23. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
24. Moi University Clinical Research Centre (Uasin Gishu county)
25. Aga Khan University Hospital (Nairobi City county)
26. Kenya Medical Research Institute (Kisumu county)
27. KEMRI/Walter Reed Project Research Center (Kericho county)
28. Ganjoni Clinic (Mombasa county)
29. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
30. Kenya Medical Research Institute (Nairobi City county)
31. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
32. Moi University Clinical Research Centre (Uasin Gishu county)
33. Aga Khan University Hospital (Nairobi City county)
34. Kenya Medical Research Institute (Kisumu county)
35. KEMRI/Walter Reed Project Research Center (Kericho county)
36. Ganjoni Clinic (Mombasa county)
37. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
38. Kenya Medical Research Institute (Nairobi City county)
39. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
40. Moi University Clinical Research Centre (Uasin Gishu county)
41. Aga Khan University Hospital (Nairobi City county)
 
View

190.

ECCT/21/06/05   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR-PHRD THIKA PROJECT
 
View